Congrats on taking some gains during that run-up. I didn't
Congrats on taking some gains during that run-up. I didn't take advantage of that, and I'm okay with that decision. Holding for the long-term payout here.
My conviction in where this company is headed caused me to lock in a $80K tax bill back in October on a large Roth conversion done in 2013 at a 0.036 share price. No undoing that now, and I'm paying that down every time I get paid. It's one reason I returned to work after a 2 year break, to pay that from wages instead of with shares. But if we do uplist to Nasdaq, I will sell enough from my taxable account to wipe out the balance.
I don't believe LymPro is a dud. I think it will be a fine product but will take time to gain traction in the research market. I think Gerald saw an opportunity to corner the AD diagnostic blood test market and took the actions he did to add to the benefit LymPro offers, not because it didn't pan out. I can see that once we bring the full spectrum of blood analysis assets to market, not only will new AD drugs be using multiple tests to screen patients, but many drugs previously failed will be retested under this broad blood-based test series. I believe it quite possible that AD may already have an effective treatment that previously failed due to ineffective screening methods.
I've taken a lot greater risk than most investors in this company. I'm not blind to the risk we continue to face. But one thing I won't do is trash the company because I am unhappy with my investment results to date. I'm not dissatisfied, but I also have an average price of 0.043. I know a lot of folks here are much higher than that, so that affects their frustration level.
If I ever change my outlook on the company's future, I'll quietly sell my shares and move on. I'll make a single post announcing my actions after it's done, and I'll wish everyone the best, but I won't post after I've exited the investment. I'm certainly not going to trash the company publicly while I'm trying to reduce or eliminate my holdings. Only a moron would do that, but that's just my opinion.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Remember the days when the FBI felt like a mythical fortress of surveillance and high-tech wizardry? Today, we're seeing one of its key veterans, Marcus Thomas, take a different path—a path that's as gritty and necessary as any Wall Street hustle. He's jumping onto the board of Re-fined, a Denver nonprofit aiming to give survivors of sexual exploitation and human...
Continue Reading
CEER's Ambitious Leap in Automotive Innovation There's a new kid on the automotive block, and it's making some serious noise. Straight out of Jeddah, CEER has just taken the wraps off their flagship electric sedan and SUV, dubbed the EXOBOT. No small beans here—this is a full-throttle, Saudi-driven pitch into the global automotive circus. And why not? There's oil in...
Continue Reading
When it comes to honoring legacy and future within the Black beauty industry, the 2026 Beauty Icon Awards seem ready to steal the spotlight. Set to take place on October 10th at Atlanta's Riverside EpiCenter, this gathering is more than just a fancy shindig – it's a tribute to Black beauty's massive influence on culture and commerce. Celebrating Pioneers and Innovators...
Continue Reading
Reimagining Streaming: GRAI Buys Hangout FM The music streaming game has just been dealt a fresh hand. GRAI, an AI-driven music company, has snatched up Hangout FM, looking to ignite a social revolution in how we experience music. Sitting here, I'm thinking about all those playlists we've built but never truly shared. This acquisition might just change that by combining...
Continue Reading
A Fresh Start for Young Careers with CareerPath You remember the time in life when we thought just having a degree meant something? Well, the game’s changed, and now it’s a twisted jungle where young folks struggle to find their footing. Partners International, a name I’m no stranger to—known for their human capital wizardry—seems to have noticed this chaotic...
Continue Reading
AI's New Role in Wealth Management Just when you think you've seen it all, along comes a partnership that shakes things up. Beemo Automation is teaming up with Choreo, a heavyweight in the tax-focused registered investment adviser world, to infuse some AI prowess where it matters. Choreographing their moves, they're looking to build something that's not just functional...
Continue Reading
Shaking Up the Job Market with AI Skills What's shaking things up this time around? Handshake's dramatic unveiling of its AI Skills Studio, that's what. While the world spins on its financial axis, Handshake's showing up with a toolkit that's not just geeky gobbledygook. They're dead set on prepping job seekers with the nitty-gritty of AI know-how hosted in a rather...
Continue Reading
Pioneering Leadership for Children's Brain Tumor Network In a world where every advance in pediatric oncology can make a measurable difference, the Children's Brain Tumor Network (CBTN) has just unveiled quite the ace up its sleeve: Dr. Sarah Leary. She's stepping in as Co-Chair of its Executive Board, taking the reins alongside Brian Rood, MD. With extensive experience...
Continue Reading
iFranchise's Unyielding Dominance in Franchise Consulting Five seconds in the franchise game, and you'd know that staying on top is a grind. But when you're iFranchise Group, it seems like the eighth time is the charm—if there ever was a need for luck. These folks have secured the number one spot in Entrepreneur magazine's Top Franchise Suppliers ranking yet again....
Continue Reading
Unifying Molecular Diagnostics for Better Cancer Care In the chaos of today’s healthcare, Aranscia is aiming to rewrite the book on how we handle cancer diagnostics by teaming up with Northside Hospital Cancer Institute. Now, instead of fumbling through disconnected systems, they plan to glue the pieces together with a blend of their own and borrowed tech. This...
Continue Reading
Top 5 Most Recently Viewed Articles
Celebrate the Festive Season at Deck the Vault The Metropolitan at The 9's legendary speakeasy bar, The Vault, welcomes you to the enchanting holiday pop-up bar, Deck the Vault. This Christmas-themed experience transforms the venue into a magical winter wonderland perfect for those looking to immerse themselves in festive cheer. A Delightful Destination for Holiday...
Continue Reading
Understanding the Anticipated Rate Cuts by the Federal Reserve JPMorgan has recently sparked interest with its analysis regarding potential rate cuts by the Federal Reserve. As conversations about the economy's resilience continue nationwide, there is a cautiously optimistic consensus, though the complexities involved are well recognized. Insights from JPMorgan's Analysis...
Continue Reading
Volkswagen's Commitment to Collaboration Volkswagen, a leading German automaker, has expressed its eagerness to collaborate with the U.S. government. This intention underscores the significance of maintaining open communication lines amidst the turbulence created by proposed tariffs. Concerns Over Proposed Tariffs The automaker has articulated its worries regarding the...
Continue Reading
Back in 2024, Apple Inc. (NASDAQ: AAPL) made waves as its stock surged dramatically, hitting a record high of $237.49—a hefty 2.7% jump on that particular day. This rally underscored Apple’s dominance as the largest publicly traded company, flaunting a staggering market cap over $3.6 trillion. Investors were gobbling up shares, with the stock skyrocketing 37% over six...
Continue Reading
Integrated Pain Associates Expands Through Strategic Partnership Integrated Pain Associates (IPA) is thrilled to share news of its partnership with Lubbock Spine Institute (LSI), a recognized name in interventional spine and pain management services. This partnership aims to strengthen patient access to comprehensive care across the region. Enhancing Service Reach and...
Continue Reading
